Search

Author/Creator Nuyens, Sarah

1. ACTR-39. TWO-YEAR RESULTS OF THE INTELLANCE 2/EORTC TRIAL 1410 RANDOMIZED PHASE II STUDY ON DEPATUX–M ALONE, DEPATUX-M COMBINED WITH TEMOZOLOMIDE (TMZ) AND EITHER TMZ OR LOMUSTINE IN RECURRENT EGFR AMPLIFIED GLIOBLASTOMA (NCT02343406. (5th November 2018)

Authors:
van den Bent, Martin; French, Pim; Eoli, Marica; Sepulveda, Juan; Walenkamp, Annemiek; Frenel, Jean-Sebastian; Franceschi, Enrico; Clement, Paul; Weller, Michael; de Heer, Iris; Looman, Jim; Dey, Jyotirmoy; Krause, Scott; Xiong, Hao; Ansell, Peter; Nuyens, Sarah; Brilhante, Joana; Spruyt, Maarten...
Journal:
Neuro-oncology
Issue:
Volume 20(2018)Supplement 6
Page Start:
vi20
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study. Issue 6 (June 2021)

Authors:
van den Bent, Martin J; Tesileanu, C Mircea S; Wick, Wolfgang; Sanson, Marc; Brandes, Alba Ariela; Clement, Paul M; Erridge, Sarah; Vogelbaum, Michael A; Nowak, Anna K; Baurain, Jean Français; Mason, Warren P; Wheeler, Helen; Chinot, Olivier L; Gill, Sanjeev; Griffin, Matthew; Rogers, Leland; Taa...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 6(2021)
Page Start:
813
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Corrigendum to INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma. Issue 8 (1st July 2020)

Authors:
van den Bent, Martin; Eoli, Marica; Sepulveda, Juan Manuel; Smits, Marion; Walenkamp, Annemiek; Frenel, Jean-Sebastian; Franceschi, Enrico; Clement, Paul M; Chinot, Olivier; de Vos, Filip; Whenham, Nicolas; Sanghera, Paul; Weller, Michael; Dubbink, H J; French, Pim; Looman, Jim; Dey, Jyotirmoy; K...
Journal:
Neuro-oncology
Issue:
Volume 23:Issue 8(2021)
Page Start:
1415
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Impact of depatuxizumab mafodotin on health-related quality of life and neurological functioning in the phase II EORTC 1410/INTELLANCE 2 trial for EGFR-amplified recurrent glioblastoma. (April 2021)

Authors:
Clement, Paul M.J.; Dirven, Linda; Eoli, Marica; Sepulveda-Sanchez, Juan M.; Walenkamp, Annemiek M.E.; Frenel, Jean S.; Franceschi, Enrico; Weller, Michael; Chinot, Olivier; De Vos, Filip Y.F.L.; Whenham, Nicolas; Sanghera, Paul; Looman, Jim; Kundu, Madan G.; Peter de Geus, Jan; Nuyens, Sarah; Sp...
Journal:
European journal of cancer
Issue:
Volume 147(2021)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. INTELLANCE 2/EORTC 1410 randomized phase II study of Depatux-M alone and with temozolomide vs temozolomide or lomustine in recurrent EGFR amplified glioblastoma. Issue 5 (20th November 2019)

Authors:
Van Den Bent, Martin; Eoli, Marica; Sepulveda, Juan Manuel; Smits, Marion; Walenkamp, Annemiek; Frenel, Jean-Sebastian; Franceschi, Enrico; Clement, Paul M; Chinot, Olivier; De Vos, Filip; Whenham, Nicolas; Sanghera, Paul; Weller, Michael; Dubbink, H J; French, Pim; Looman, Jim; Dey, Jyotirmoy; K...
Journal:
Neuro-oncology
Issue:
Volume 22:Issue 5(2020)
Page Start:
684
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study. Issue 10103 (7th October 2017)

Authors:
van den Bent, Martin J; Baumert, Brigitta; Erridge, Sara C; Vogelbaum, Michael A; Nowak, Anna K; Sanson, Marc; Brandes, Alba Ariela; Clement, Paul M; Baurain, Jean Francais; Mason, Warren P; Wheeler, Helen; Chinot, Olivier L; Gill, Sanjeev; Griffin, Matthew; Brachman, David G; Taal, Walter; Rudà,...
Journal:
Lancet
Issue:
Volume 390:Issue 10103(2017)
Page Start:
1645
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. RBTT-08. EORTC 1709/CCTG CE.8: A PHASE III TRIAL OF MARIZOMIB IN COMBINATION WITH STANDARD TEMOZOLOMIDE-BASED RADIOCHEMOTHERAPY VERSUS STANDARD TEMOZOLOMIDE-BASED RADIOCHEMOTHERAPY ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA. (5th November 2018)

Authors:
Roth, Patrick; Reijneveld, Jaap; Gorlia, Thierry; Dhermain, Frederic; Vanlancker, Maureen; Fournier, Beatrice; Nuyens, Sarah; O'Callaghan, Chris; Le Rhun, Emilie; Elias, Ileana; van den Bent, Martin; Mason, Warren; Winograd, Benjamin; Weller, Michael
Journal:
Neuro-oncology
Issue:
Volume 20(2018)Supplement 6
Page Start:
vi235
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗